articleCancer CellMar 1, 2025HYBRID OA

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients

Inserm · Université Paris-Saclay · +37 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

T cell activation without exhaustion. Various strains of Christensenella minuta selectively boost the anti-cancer efficacy of ILDR and PD-L1 blockade, allowing emigration of intestinal PD-L1-expressing dendritic cells to tumor-draining lymph nodes. An interventional phase 2 study provides the proof-of-concept that ILDR can circumvent resistance to first- or second-line immunotherapy in cancer patients. Prospective clinical trials are warranted to define optimal dosimetry and indications for ILDR to maximize its therapeutic potential.

No related works found for this paper.

Funding